Buchumschlag

First-in-human brain imaging of [18F]TRACK, a PET tracer for tropomyosin receptor kinases

The tropomyosin receptor kinase TrkA/B/C family is responsible for human neuronal growth, survival, and differentiation from early nervous system development stages onward. Downregulation of TrkA/B/C receptors characterizes numerous neurological disorders including Alzheimer’s disease (AD). Abnormal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bailey, Justin (VerfasserIn) , Kaiser, Lena (VerfasserIn) , Lindner, Simon (VerfasserIn) , Wüst, Melinda (VerfasserIn) , Thiel, Alexander (VerfasserIn) , Soucy, Jean-Paul (VerfasserIn) , Rosa-Neto, Pedro (VerfasserIn) , Scott, Peter J. H. (VerfasserIn) , Unterrainer, Marcus (VerfasserIn) , Kaplan, David R. (VerfasserIn) , Wängler, Carmen (VerfasserIn) , Wängler, Björn (VerfasserIn) , Bartenstein, Peter (VerfasserIn) , Bernard-Gauthier, Vadim (VerfasserIn) , Schirrmacher, Ralf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: ACS chemical neuroscience
Year: 2019, Jahrgang: 10, Heft: 6, Pages: 2697-2702
ISSN:1948-7193
DOI:10.1021/acschemneuro.9b00144
Online-Zugang:Verlag, Volltext: https://doi.org/10.1021/acschemneuro.9b00144
Volltext
Verfasserangaben:Justin J. Bailey, Lena Kaiser, Simon Lindner, Melinda Wüst, Alexander Thiel, Jean-Paul Soucy, Pedro Rosa-Neto, Peter J.H. Scott, Marcus Unterrainer, David R. Kaplan, Carmen Wängler, Björn Wängler, Peter Bartenstein, Vadim Bernard-Gauthier, and Ralf Schirrmacher
Beschreibung
Zusammenfassung:The tropomyosin receptor kinase TrkA/B/C family is responsible for human neuronal growth, survival, and differentiation from early nervous system development stages onward. Downregulation of TrkA/B/C receptors characterizes numerous neurological disorders including Alzheimer’s disease (AD). Abnormally expressed Trk receptors or chimeric Trk fusion proteins are also well-characterized oncogenic drivers in a variety of neurogenic and non-neurogenic human neoplasms and are currently the focus of intensive clinical research. Previously, we have described the clinical translation of a highly selective and potent carbon-11-labeled pan-Trk radioligand and the preclinical characterization of the optimized fluorine-18-labeled analogue, [18F]TRACK, for in vivo Trk positron emission tomography (PET) imaging. We describe herein central nervous system selectivity assessment and first-in-human study of [18F]TRACK.
Beschreibung:Gesehen am 26.09.2019
Publication date: April 24, 2019
Die 18 im Titel ist hochgestellt
Beschreibung:Online Resource
ISSN:1948-7193
DOI:10.1021/acschemneuro.9b00144

Ähnliche Einträge